N-Back

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 7770 Experts worldwide ranked by ideXlab platform

Markus Antonietti - One of the best experts on this subject based on the ideXlab platform.

Maria Magdalena Titirici - One of the best experts on this subject based on the ideXlab platform.

Arne Thomas - One of the best experts on this subject based on the ideXlab platform.

Sisinthy Shivaji - One of the best experts on this subject based on the ideXlab platform.

  • Tolazoline antagonises ketamine–xylazine anaesthesia in an endangered Black buck (Antilope cervicapra)
    European Journal of Wildlife Research, 2009
    Co-Authors: Sadanand D. Sontakke, Govindaswamy Umapathy, Manoj S. Patil, Sisinthy Shivaji
    Abstract:

    Seventy-seven anaesthetic events were carried out in 22 captive adult Black bucks ( Antilope cervicapra ) of either sex with a combination of 2 mg kg^−1 ketamine hydrochloride with 0.25 mg kg^−1 xylazine hydrochloride using a dart delivered from a blowpipe. Randomised anaesthetised animals received an intravenous injection of either yohimbine hydrochloride (0.125 or 0.25 mg kg^−1) or tolazoline hydrochloride (1 or 2 mg kg^−1) after 30–40 min of anaesthesia to antagonise the anaesthetic effects. Ketamine–xylazine induced smooth, rapid and reliable anaesthesia within 5–7 min of darting with no clinical adverse effects and causalities during or post-anaesthesia. Yohimbine failed to antagonise the anaesthetic effects of ketamine–xylazine in the Black buck. On the other hand, tolazoline was found to be very effective in hastening recovery in dose-dependent manner within 0.5–1.5 min. This study documents the first report of ketamine–xylazine anaesthesia and its antagonism by tolazoline in captive Black buck.

  • tolazoline antagonises ketamine xylazine anaesthesia in an endangered black buck antilope cervicapra
    European Journal of Wildlife Research, 2009
    Co-Authors: Sadanand D. Sontakke, Govindaswamy Umapathy, Manoj S. Patil, Sisinthy Shivaji
    Abstract:

    Seventy-seven anaesthetic events were carried out in 22 captive adult Black bucks (Antilope cervicapra) of either sex with a combination of 2 mg kg−1 ketamine hydrochloride with 0.25 mg kg−1 xylazine hydrochloride using a dart delivered from a blowpipe. Randomised anaesthetised animals received an intravenous injection of either yohimbine hydrochloride (0.125 or 0.25 mg kg−1) or tolazoline hydrochloride (1 or 2 mg kg−1) after 30–40 min of anaesthesia to antagonise the anaesthetic effects. Ketamine–xylazine induced smooth, rapid and reliable anaesthesia within 5–7 min of darting with no clinical adverse effects and causalities during or post-anaesthesia. Yohimbine failed to antagonise the anaesthetic effects of ketamine–xylazine in the Black buck. On the other hand, tolazoline was found to be very effective in hastening recovery in dose-dependent manner within 0.5–1.5 min. This study documents the first report of ketamine–xylazine anaesthesia and its antagonism by tolazoline in captive Black buck.

Gunnar B J Andersson - One of the best experts on this subject based on the ideXlab platform.

  • nonsurgical management of acute and chronic low back pain
    Journal of The American Academy of Orthopaedic Surgeons, 2006
    Co-Authors: Francis H Shen, D Samartzis, Gunnar B J Andersson
    Abstract:

    A variety of nonsurgical treatment alternatives exists for acute and chronic low back pain. Patients should receive appropriate education about the favorable natural history of low back pain, basic body mechanics, and methods (eg, exercises, activity modification, behavioral modification) that can reduce symptoms. Nonprescription medication is efficacious for mild to moderate pain. Nonsteroidal anti-inflammatory drugs, alone or in combination with muscle relaxants, relieve pain and improve overall symptoms of acute low back pain. Exercise therapy has limited value for acute low back pain, but strong evidence supports exercise therapy in the management of chronic low back pain. Moderately strong evidence supports the use of manipulation in acute back pain. Evidence is weak for the use of epidural corticosteroid injections in patients with acute low back pain, strong for short-term relief of chronic low back pain, and limited for long-term relief of chronic low back pain. The use of facet injections in the management of acute low back pain is not supported by evidence, nor is the effectiveness of orthoses, traction, magnets, or acupuncture. Trigger point injections are not indicated for nonspecific acute or chronic low back pain, and sacroiliac joint injections are not indicated in the routine management of low back pain. Conflicting evidence exists regarding the use of transcutaneous electrical nerve stimulation.